Napsin A expression in small cell carcinoma of the lung

A cytologic study with review of differentials

Kim HooKim, Sravan Kumar Kavuri, Scott R. Lauer, Cynthia Cohen, Michelle D. Reid

Research output: Contribution to journalArticle

Abstract

Introduction: Napsin A is a diagnostic marker for pulmonary adenocarcinoma and a useful alternative to thyroid transcription factor 1 (TTF-1). TTF-1 also stains pulmonary small cell carcinoma (SCCA). Napsin A expression in SCCAs is not as established as it is in non-SCCAs. We analyzed napsin A and TTF-1 expression in 36 previously confirmed cytologic cases of pulmonary SCCA. Ours is currently the largest cytologic series of such cases examined for napsin A expression. Materials and Methods: Thirty-six patients, (20 men, 16 women), age 43-87 years, mean 57 years, had primary or metastatic pulmonary SCCA diagnosed by fine-needle aspiration biopsies of mediastinum (n = 5); liver (n = 3); subcutaneous nodule (n = 1); lung (n = 6); and axillary, cervical, and mediastinal lymph nodes (n = 20), as well as a pleural effusion (n = 1). Napsin A and TTF-1 expression was tested. Also, previous expression (or lack thereof) with immunocytochemical stains pancytokeratin and neuroendocrine markers (synaptophysin, chromogranin, and cluster of differentiation marker CD56) were noted. Results: All cases of pulmonary SCCA were positive for pancytokeratin. TTF-1 was positive in 35 of 36 cases (97%), and napsin A was negative in all 36 cases (100%). All 36 cases expressed ≥ 1 neuroendocrine marker, including the TTF-1 negative case. Conclusions: This study showed napsin A was negative in all pulmonary SCCAs. This stain may prove to be a useful exclusionary marker in distinguishing pulmonary SCCA from other poorly differentiated lung carcinomas with similar morphologic features, especially those with concomitant TTF-1 expression.

Original languageEnglish (US)
Pages (from-to)90-95
Number of pages6
JournalJournal of the American Society of Cytopathology
Volume3
Issue number2
DOIs
StatePublished - Mar 1 2014

Fingerprint

Small Cell Lung Carcinoma
Small Cell Carcinoma
Lung
Coloring Agents
CD Antigens
Chromogranins
Synaptophysin
Mediastinum
Pleural Effusion
Fine Needle Biopsy
thyroid nuclear factor 1
Lymph Nodes
Carcinoma
Liver

Keywords

  • Cytology
  • Lung
  • Napsin A
  • Small cell carcinoma
  • Thyroid transcription factor1

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Napsin A expression in small cell carcinoma of the lung : A cytologic study with review of differentials. / HooKim, Kim; Kavuri, Sravan Kumar; Lauer, Scott R.; Cohen, Cynthia; Reid, Michelle D.

In: Journal of the American Society of Cytopathology, Vol. 3, No. 2, 01.03.2014, p. 90-95.

Research output: Contribution to journalArticle

@article{3ee9b45c0850436ab930f5a61f0641dd,
title = "Napsin A expression in small cell carcinoma of the lung: A cytologic study with review of differentials",
abstract = "Introduction: Napsin A is a diagnostic marker for pulmonary adenocarcinoma and a useful alternative to thyroid transcription factor 1 (TTF-1). TTF-1 also stains pulmonary small cell carcinoma (SCCA). Napsin A expression in SCCAs is not as established as it is in non-SCCAs. We analyzed napsin A and TTF-1 expression in 36 previously confirmed cytologic cases of pulmonary SCCA. Ours is currently the largest cytologic series of such cases examined for napsin A expression. Materials and Methods: Thirty-six patients, (20 men, 16 women), age 43-87 years, mean 57 years, had primary or metastatic pulmonary SCCA diagnosed by fine-needle aspiration biopsies of mediastinum (n = 5); liver (n = 3); subcutaneous nodule (n = 1); lung (n = 6); and axillary, cervical, and mediastinal lymph nodes (n = 20), as well as a pleural effusion (n = 1). Napsin A and TTF-1 expression was tested. Also, previous expression (or lack thereof) with immunocytochemical stains pancytokeratin and neuroendocrine markers (synaptophysin, chromogranin, and cluster of differentiation marker CD56) were noted. Results: All cases of pulmonary SCCA were positive for pancytokeratin. TTF-1 was positive in 35 of 36 cases (97{\%}), and napsin A was negative in all 36 cases (100{\%}). All 36 cases expressed ≥ 1 neuroendocrine marker, including the TTF-1 negative case. Conclusions: This study showed napsin A was negative in all pulmonary SCCAs. This stain may prove to be a useful exclusionary marker in distinguishing pulmonary SCCA from other poorly differentiated lung carcinomas with similar morphologic features, especially those with concomitant TTF-1 expression.",
keywords = "Cytology, Lung, Napsin A, Small cell carcinoma, Thyroid transcription factor1",
author = "Kim HooKim and Kavuri, {Sravan Kumar} and Lauer, {Scott R.} and Cynthia Cohen and Reid, {Michelle D.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1016/j.jasc.2013.11.005",
language = "English (US)",
volume = "3",
pages = "90--95",
journal = "Journal of the American Society of Cytopathology",
issn = "2213-2945",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Napsin A expression in small cell carcinoma of the lung

T2 - A cytologic study with review of differentials

AU - HooKim, Kim

AU - Kavuri, Sravan Kumar

AU - Lauer, Scott R.

AU - Cohen, Cynthia

AU - Reid, Michelle D.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Introduction: Napsin A is a diagnostic marker for pulmonary adenocarcinoma and a useful alternative to thyroid transcription factor 1 (TTF-1). TTF-1 also stains pulmonary small cell carcinoma (SCCA). Napsin A expression in SCCAs is not as established as it is in non-SCCAs. We analyzed napsin A and TTF-1 expression in 36 previously confirmed cytologic cases of pulmonary SCCA. Ours is currently the largest cytologic series of such cases examined for napsin A expression. Materials and Methods: Thirty-six patients, (20 men, 16 women), age 43-87 years, mean 57 years, had primary or metastatic pulmonary SCCA diagnosed by fine-needle aspiration biopsies of mediastinum (n = 5); liver (n = 3); subcutaneous nodule (n = 1); lung (n = 6); and axillary, cervical, and mediastinal lymph nodes (n = 20), as well as a pleural effusion (n = 1). Napsin A and TTF-1 expression was tested. Also, previous expression (or lack thereof) with immunocytochemical stains pancytokeratin and neuroendocrine markers (synaptophysin, chromogranin, and cluster of differentiation marker CD56) were noted. Results: All cases of pulmonary SCCA were positive for pancytokeratin. TTF-1 was positive in 35 of 36 cases (97%), and napsin A was negative in all 36 cases (100%). All 36 cases expressed ≥ 1 neuroendocrine marker, including the TTF-1 negative case. Conclusions: This study showed napsin A was negative in all pulmonary SCCAs. This stain may prove to be a useful exclusionary marker in distinguishing pulmonary SCCA from other poorly differentiated lung carcinomas with similar morphologic features, especially those with concomitant TTF-1 expression.

AB - Introduction: Napsin A is a diagnostic marker for pulmonary adenocarcinoma and a useful alternative to thyroid transcription factor 1 (TTF-1). TTF-1 also stains pulmonary small cell carcinoma (SCCA). Napsin A expression in SCCAs is not as established as it is in non-SCCAs. We analyzed napsin A and TTF-1 expression in 36 previously confirmed cytologic cases of pulmonary SCCA. Ours is currently the largest cytologic series of such cases examined for napsin A expression. Materials and Methods: Thirty-six patients, (20 men, 16 women), age 43-87 years, mean 57 years, had primary or metastatic pulmonary SCCA diagnosed by fine-needle aspiration biopsies of mediastinum (n = 5); liver (n = 3); subcutaneous nodule (n = 1); lung (n = 6); and axillary, cervical, and mediastinal lymph nodes (n = 20), as well as a pleural effusion (n = 1). Napsin A and TTF-1 expression was tested. Also, previous expression (or lack thereof) with immunocytochemical stains pancytokeratin and neuroendocrine markers (synaptophysin, chromogranin, and cluster of differentiation marker CD56) were noted. Results: All cases of pulmonary SCCA were positive for pancytokeratin. TTF-1 was positive in 35 of 36 cases (97%), and napsin A was negative in all 36 cases (100%). All 36 cases expressed ≥ 1 neuroendocrine marker, including the TTF-1 negative case. Conclusions: This study showed napsin A was negative in all pulmonary SCCAs. This stain may prove to be a useful exclusionary marker in distinguishing pulmonary SCCA from other poorly differentiated lung carcinomas with similar morphologic features, especially those with concomitant TTF-1 expression.

KW - Cytology

KW - Lung

KW - Napsin A

KW - Small cell carcinoma

KW - Thyroid transcription factor1

UR - http://www.scopus.com/inward/record.url?scp=84894029540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894029540&partnerID=8YFLogxK

U2 - 10.1016/j.jasc.2013.11.005

DO - 10.1016/j.jasc.2013.11.005

M3 - Article

VL - 3

SP - 90

EP - 95

JO - Journal of the American Society of Cytopathology

JF - Journal of the American Society of Cytopathology

SN - 2213-2945

IS - 2

ER -